Back
IMAX Corp. 10K Form
Buy
77
IMAX
IMAX Corp.
Last Price:
$36.24
Seasonality Move:
13.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-25 | 10Q | IMAX/IMAX Corp. Quarterly |
| 2023-07-26 | 10Q | IMAX/IMAX Corp. Quarterly |
| 2023-04-27 | 10Q | IMAX/IMAX Corp. Quarterly |
| 2022-10-31 | 10Q | IMAX/IMAX Corp. Quarterly |
| 2022-07-29 | 10Q | IMAX/IMAX Corp. Quarterly |
| 2022-04-28 | 10Q | IMAX/IMAX Corp. Quarterly |
Receive IMAX News And Ratings
See the #1 stock for the next 7 days that we like better than IMAX
IMAX Financial Statistics
Sales & Book Value
| Annual Sales: | $352.2M |
|---|---|
| Cash Flow: | $65.1M |
| Price / Cash Flow: | 22.01 |
| Annual Sales: | $6.50 |
| Price / Book: | 5.58 |
Profitability
| EPS (TTM): | 0.71510 |
|---|---|
| Net Income (TTM): | $49.9M |
| Gross Margin: | $185.9M |
| Return on Equity: | 12.64% |
| Return on Assets: | 5.82% |
IMAX Corp. Earnings Forecast
Key IMAX Corp. Financial Ratios
-
The Gross Profit Margin over the past 31 years for IMAX is 52.79%.
-
The Selling, General & Administrative Expenses for IMAX have been equal to 37.68% of Gross Profit Margin.
-
The Research & Development expenses have been 0.91% of Revenue.
-
The Interest Expense is 24.72% of Operating Income.
-
The Net Earning history of IMAX is 9.28% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 16 years.
IMAX Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Entertainment |
| Sector: | Communication Services |
| Current Symbol: | IMAX |
| CUSIP: | 45245E |
| Website: | imax.com |
Debt
| Debt-to-Equity Ratio: | 0.74 |
|---|---|
| Current Ratio: | 1.84 |
| Quick Ratio: | 1.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 74.89 |
|---|---|
| Forward P/E Ratio: | 22.88 |
IMAX Technical Analysis vs Fundamental Analysis
Buy
77
IMAX Corp. (IMAX)
is a Buy
Is IMAX Corp. a Buy or a Sell?
-
IMAX Corp. stock is rated a BuyThe current IMAX Corp. [IMAX] share price is $36.23. The Score for IMAX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.